Comparison of allelic losses in chondroblastoma and primary chondrosarcoma of bone and correlation with fluorescence in situ hybridization analysis

Human Pathology

Volumn 37, Issue 7, 2006, Pages 890-898

  Papachristou, Dionysios J ^a   Goodman, Mark A ^a   Cieply, Katheleen ^a   Hunt, Jennifer L ^a   Rao, Uma N M ^a  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Allelic loss; Bone; Chondroblastoma; Chondrosarcoma; Fractional allelic loss; Genes

Indexed keywords

PROTEIN; PROTEIN ERC; PROTEIN P16; PROTEIN P53; PROTEIN XRCC; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CARCINOGENESIS; CHONDROBLASTOMA; CHONDROSARCOMA; CHROMOSOME 11; CHROMOSOME 11P; CHROMOSOME 13; CHROMOSOME 13Q; CHROMOSOME 17; CHROMOSOME 19; CHROMOSOME 19Q; CHROMOSOME 5; CHROMOSOME 5Q; CHROMOSOME 9; CHROMOSOME 9P; CLINICAL ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HETEROZYGOSITY LOSS; HUMAN; MALE; MICRODISSECTION; POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHONDROBLASTOMA; CHONDROSARCOMA; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 33745130339     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.02.014     Document Type: Article

References (48)

1. Kilpatrick S.E., Parisien M., and Bridge J.A. Chondroblastoma. In: Fletcher C.D.M., Unni K.K., and Mertens F. (Eds). World Health Organization classification of tumors. Pathology and genetics of tumors of soft tissue and bone (2002), IARC Press, Lyon (France) 241-242
2. Sprinfield D.S., Capanna R., Cherlinzoni F., et al. Chondroblastoma: a review of seventy cases. J Bone Joint Surg Am 67 (1985) 748-755
3. Jaffe H.L., and Lichtenstein L. Benign chondroblastoma of bone. Am J Pathol 18 (1942) 969-991
4. Turcotte R.E., Kurt A.M., Sim F.H., et al. Chondroblastoma. Hum Pathol 24 (1993) 944-949
5. Davila J.A., Amrami K.K., Sundaram M., et al. Chondroblastoma of hands and feet. Skeletal Radiol 33 (2004) 582-587
6. Ilaslan H., Sundaram M., and Unni K.K. Vertebral chondroblastoma. Skeletal Radiol 32 (2003) 599-604
7. Green P., and Whittaker R.P. Benign chondroblastoma. Case report with pulmonary metastasis. J Bone Joint Surg Am 57 (1975) 418-420
8. Ostrowski M.L., Johnson M.E., Truong L.D., et al. Malignant chondroblastoma presenting as a recurrent pelvic tumor with DNA aneuploidy and p53 mutation as supportive evidence of malignancy. Skeletal Radiol 28 (1999) 644-650
9. Rodgers W.B., and Mankin H.J. Metastatic malignant chondroblastoma. Am J Orthop 12 (1996) 846-849
10. Wirman J.A., Crissman J.D., and Aron B.F. Metastatic chondroblastoma: report of an unusual case treated with radiotherapy. Cancer 44 (1979) 87-93
11. Romeo S., Bovee J.V.M.G., Jadnanasing N.A.A., et al. Expression of cartilage growth plate signaling molecules in chondroblastoma. J Pathol 202 (2004) 113-120
12. Aigner T., Loss S., Inwards C., et al. Chondroblastoma is an osteoid-forming but not cartilage-forming neoplasm. J Pathol 189 (1999) 463-469
13. Huang L., Cheng Y.Y., Chow L.T.C., et al. Receptor activator of NF-κB ligand (RANKL) is expressed in chondroblastoma: possible involvement in osteoclastic giant cell recruitment. Mol Pathol 56 (2003) 116-120
14. Sandberg A.A., and Bridge J.A. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcomas and other cartilaginous neoplasms. Cancer Genet Cytogenet 143 (2003) 1-31
15. Sandberg A.A. Genetics of chondrosarcoma and related tumors. Curr Opin Oncol 16 (2004) 342-354
16. El-Naggar A.K., Hurr K., Tu Z.N., et al. DNA and RNA content analysis by flow cytometry in the pathologic assessment of bone tumors. Cytometry 19 (1995) 256-262
17. Swarts S.J., Neff J.R., Johansson S.L., et al. Significance of abnormalities of chromosomes 5 and 8 in chondroblastoma. Clin Orthop 349 (1998) 189-193
18. van Beerendonk H.M., Rozeman L.B., Taminiau A.H.M., et al. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumor progression. J Pathol 202 (2004) 359-366
19. Mandahl N., Gustafson F., Mertens F., et al. Cytogenetic aberrations and their prognostic impact on chondrosarcoma. Genes Chromosomes Cancer 33 (2002) 188-200
20. Unni K.K. Cartilaginous lesions of bone. J Orthop Sci 6 (2001) 457-472
21. Rao U.N.M., Goodman M., Chung W.W., et al. Molecular analysis of primary and recurrent giant cell tumors of bone. Cancer Genet Cytogenet 158 (2005) 126-136
22. Hunt J.L., Carty S.E., Yim J.H., et al. Allelic loss in parathyroid neoplasia can help characterize malignancy. Am J Surg Pathol 29 (2005) 1049-1055
23. van Zelderen-Bhola S.L., Bovee J.V.MG., Wessels H.W., et al. Ring chromosome 4 as the sole cytogenetic anomaly in a chondroblastoma: a case report and review of the literature. Cancer Genet Cytogenet 105 (1998) 109-112
24. Agarwal M.L., Taylor W.R., Chernov M.V., et al. The p53 network. J Biol Chem 273 (1998) 1-4
25. Isobe M., Emanuel B.S., Givol D., et al. Localization of gene for human p53 tumor antigen to band 17p13. Nature 320 (1986) 84-85
26. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
27. Arakawa H. Review. p53 apoptosis and axon guidance molecules. Cell Death Differ 12 (2005) 1057-1065
28. Bovee J.V.M.G., Clenton-Jansen A.M., Kuipers-Dijkshoorn N.J., et al. Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma. Genes Chromosomes Cancer 26 (1999) 237-246
29. Grote H.J., Schneider-Stock R., Neumann D., et al. Mutations of p53 with loss of heterozygosity in the osteosarcomatous component of a dedifferentiated chondrosarcoma. Virchows Arch 436 (2000) 494-497
30. Oshiro Y., Chatruvedi V., Hayden D., et al. Altered p53 is associated with aggressive behavior in chondrosarcoma: a long term follow-up study. Cancer 83 (1998) 2324-2334
31. Ropke M., Boltze C., Neumann H.W., et al. Genetic and epigenetic alterations in tumor progression in a dedifferentiated chondrosarcoma. Pathol Res Pract 199 (2003) 437-444
32. Terek R.M., Healey J.H., Garin-Chesa P., et al. p53 mutations in chondrosarcoma. Diagn Mol Pathol 7 (1998) 51-56
33. Asp J., Inerot S., Block J.A., et al. Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosarcomas. J Orthop Res 19 (2001) 149-154
34. Asp J., Sangori L., Inerot S.E., et al. Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues. Int J Cancer 85 (2000) 782-786
35. Hartmann A., Rosner U., Schlake G., et al. Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis. Lab Invest 80 (2000) 709-718
36. Woenckhaus M., Grepmeier U., Wild P.J., et al. Multitarget FISH and LOH analyses at chromosome 3 in non-small cell lung cancer and adjacent bronchial epithelium. Am J Clin Pathol 123 (2005) 752-761
37. Hunter T., and Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79 (1994) 573-582
38. Tsuchiya T., Sekine K., Hinohara S., et al. Analysis of p16INK4A, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing's sarcoma. Cancer Genet Cytogenet 120 (2000) 91-98
39. Benassi S.M., Molendini L., Gambieri G., et al. Involvement of INK4A gene products in the pathogenesis and development of human osteosarcoma. Cancer 92 (2001) 3062-3067
40. Sabah M., Cummings R., Leader M., et al. Leiomyosarcoma and malignant fibrous histiocytoma share similar allelic imbalance pattern at 9p. Virchows Arch 446 (2005) 251-258
41. Casorzo L., Chiecchio L., Piscane A., et al. Cytogenetic findings in a case of dedifferentiated chondrosarcoma. Cancer Genet Cytogenet 144 (2003) 61-64
42. Hecht J.T., Hogue D., Strong L.C., et al. Hereditary multiple exostoses and chondrosarcoma: linkage to chromosome 11 and loss of heterozygosity for EXT-linked markers on chromosomes 11 and 8. Am J Hum Genet 56 (1995) 1125-1131
43. Raskin W.H., Conrad E.U., Chansky H., et al. Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11. Am J Hum Genet 56 (1995) 1132-1139
44. Monaghan H., Bubb V.J., Sirimujalin R., et al. Adenomatous polyposis coli (APC), β-catenin, and cadherin are expressed in human bone and cartilage. Histopathology 39 (2001) 611-619
45. Kuhnen C., Herter P., Monse H., et al. APC and β-catenin in alveolar soft part sarcoma (ASPS)-immunohistochemical and molecular genetic analysis. Pathol Res Pract 196 (2000) 299-304
46. Saito T., Oda Y., Sakamoto A., et al. APC mutations in synovial sarcoma. J Pathol 196 (2002) 445-449
47. Mort R., McEwan C., and Melton D.W. Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer. Br J Cancer 89 (2003) 333-337
48. Bicher A., Ault K., Kimmelman A., et al. Loss of heterozygosity in human ovarian cancer on chromosome 19q. Gynecol Oncol 66 (1997) 36-40